NASDAQ:IRWD - Ironwood Pharmaceuticals, Inc.
$10.96
 $0.24
+2.24%
4:00PM EDT
2019-07-22
Ironwood Pharmaceuticals, Inc. is a biotechnology company. The Company is advancing product opportunities in areas of unmet need, including irritable bowel syndrome with constipation (IBS C), and chronic idiopathic constipation (CIC), hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease (uncontrolled GERD), and vascular and fibrotic diseases. It operates in human therapeutics business segment. Its product, linaclotide, is available to adult men and women suffering from IBS C or CIC in the United States under the trademarked name LINZESS, and is available to adult men and women suffering from IBS C in certain European countries under the trademarked name CONSTELLA. It is also advancing IW-3718, a gastric retentive formulation of a bile acid sequestrant with the potential to provide symptomatic relief in patients with uncontrolled GERD. Its vascular/fibrotic programs include IW-1973 and IW-1701, which targets soluble guanylate cyclase (sGC). Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  IRWD     avg for
industry  
  avg for
sector  
42 stocks weight:  30. 78   0. 00   0. 00  
42 stocks rank:  2. 92 K 1. 35 K 799. 74  
# analyst opinions:  9. 00   12. 76   13. 14  
mean recommendation:  2. 40   2. 11   2. 07  

quick ratio:  1. 62   5. 61   1. 85  
current ratio:  1. 70   6. 00   2. 31  

target price low:  11. 00   75. 88   108. 31  
target price avg:  14. 78   97. 27   130. 10  
target price high:  19. 00   124. 58   149. 02  
1-yr high:  16. 41   104. 89   135. 09  
last close:  10. 96   79. 79   118. 76  
50-day avg:  10. 77   79. 39   116. 18  
200-day avg:  11. 19   81. 61   114. 52  
1-yr low:  7. 80   62. 76   94. 70  
volume:  865. 12 K 2. 99 M 4. 43 M
50-day avg volume:  1. 33 M 3. 39 M 4. 22 M
200-day avg volume:  1. 57 M 3. 13 M 4. 83 M

1-day return:  2. 24 % 0. 33 % 0. 14 %
this week return:  2. 24 % 0. 33 % 0. 14 %
12-wk return:  3. 30 % 1. 00 % 3. 51 %
52-wk return:  -36. 30 % 0. 58 % 10. 25 %

enterprise value (EV):  2. 05 B 44. 78 B 115. 63 B
market cap:  1. 71 B 38. 01 B 103. 29 B
EBITDA:  -109. 67 M 4. 47 B 7. 73 B
enterprise multiple (EV/EBITDA):  -18. 67   2. 11   11. 26  
enterprise/revenue (EV/R):  5. 91   61. 53   10. 40  
total revenue:  346. 21 M 10. 43 B 31. 15 B
total debt:  498. 08 M 11. 72 B 16. 76 B
net income (common):  -298. 51 M 2. 06 B 3. 79 B

shares outstanding:  155. 62 M 562. 08 M 1. 27 B
shares:  142. 14 M 573. 33 M 1. 26 B
shares short:  17. 70 M 11. 60 M 12. 29 M
shares short prior month:  16. 84 M 9. 81 M 12. 46 M
short ratio:  13. 80   5. 88   3. 41  
short % of float:  13. 33 % 6. 88 % 2. 72 %
total cash/share:  0. 77   10. 62   8. 83  
total cash:  119. 05 M 6. 17 B 5. 72 B
free cash flow:  -36. 37 M 3. 08 B 3. 10 B
operating cash flow:  -82. 38 M 3. 99 B 4. 08 B

book value:  -1. 52   12. 74   26. 25  
price/book:  -7. 19   4. 38   9. 01  
gross profits:  147. 14 M 7. 93 B 35. 64 B
operating margins:  -34. 62 % -319. 65 % -29. 05 %
EBITDA margins:  -31. 68 % 11. 82 % 24. 13 %
profit margins:  -86. 22 % 5. 62 % 14. 29 %
gross margins:  37. 78 % 34. 75 % 57. 07 %

1-yr max volatility:  17. 94 % --- ---
1-yr mean volatility:  2. 50 % 1. 95 % 1. 25 %

1-yr EPS:  -1. 94   1. 58   3. 82  
forward EPS:  0. 50   3. 16   6. 65  
P/E:  -5. 64   0. 21   31. 97  
forward P/E:  21. 44   4. 95   15. 14  
PE/G:  9. 40   0. 74   0. 13  
growth:  -0. 60 % 295. 81 % 85. 47 %
earnings high:  0. 06   0. 84   1. 56  
earnings avg:  -0. 03   0. 65   1. 45  
earnings low:  -0. 19   0. 40   1. 35  
revenue high:  94. 44 M 2. 70 B 8. 76 B
revenue avg:  89. 84 M 2. 64 B 8. 62 B
revenue low:  85. 40 M 2. 58 B 8. 45 B
return on assets:  -16. 03 % -3. 43 % 4. 51 %
revenue growth:  -0. 60 % 295. 25 % 78. 55 %
revenue/share:  2. 25   12. 50   51. 58  

beta (1yr vs S&P500):  1. 43   1. 27   0. 91  
sharpe (1yr):  -0. 47   0. 20   0. 80  

held % insiders:  2. 60 % 6. 63 % 3. 46 %
held % institutions:  100. 33 % 76. 45 % 67. 87 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-22 : IRWD
.    113.787 =       113.787 :: --> INITIAL WEIGHT <--
.    - 1.943 =       111.844 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.     x 3.29 =       367.986 :: P/E factor
.    x 0.844 =       310.633 :: PE/G factor
.    x 1.673 =       519.735 :: beta factor
.    x 0.808 =       419.945 :: sharpe factor
.    x 2.284 =       958.971 :: current ratio factor
.    x 1.508 =      1446.145 :: quick ratio factor
.    x 1.036 =      1497.625 :: short ratio factor
.    x 1.096 =      1641.543 :: EV/R factor
.    x 0.889 =      1459.669 :: debt-to-revenue factor
.                               --> PERFORMANCE <--
.    x 2.759 =      4027.568 :: sector+industry 1-year gains factor
.     x 1.01 =      4067.784 :: industry 12-weeks return factor
.    x 1.309 =       5326.22 :: industry 2-weeks return factor
.    x 0.922 =      4911.936 :: company one-year gains+dividend factor
.    x 3.453 =     16960.907 :: company 13 weeks' performance factor
.    x 0.999 =     16943.466 :: "drift" penalty 5 days ago
.    / 1.942 =      8725.462 :: overall "drift" factor
.    x 0.867 =      7568.688 :: largest single-day jump factor
.    x 0.161 =      1216.831 :: low price factor
.    x 0.812 =        988.63 :: notable returns + performance factor
.    x 3.421 =      3382.223 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 0.841 =      2843.925 :: forward EPS factor
.    x 0.942 =       2679.45 :: forward P/E factor
.    x 1.184 =      3172.362 :: industry recommendation factor
.    x 1.785 =      5662.105 :: company recommendation factor
.    x 1.002 =      5670.707 :: factor historical industry gain for week 29
.    x 1.075 =      6095.752 :: target low factor
.    x 1.197 =      7295.341 :: target mean factor
.    x 1.036 =      7557.774 :: target high factor
.    x 5.064 =     38272.288 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        13.987 :: reduced for readability
.   + 15.857 =        29.844 :: add/subtract for investor sentiment
.    + 0.941 =        30.785 :: earnings report in 8 days
.                               --> FINAL WEIGHT <--
.                     30.785 :: FINAL WEIGHT for NASDAQ:IRWD


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org